WhiteBook2_Part2 - 12

Results
For the major topic, over a fifth of the 120 research priorities were described by the national
societies as drug therapy research (Figure 2). Combined, drug therapy (22%), diagnosis
(13%), and prevention and control (12%) research made up nearly half of all the identified
research priorities. Healthcare quality, access and evaluation research, and epidemiological
research accounted for 11% and 9% of the priorities, respectively.
Results were similar when investigating the percentage of societies that prioritised each
topic, with drug therapy research prioritised by 52% of the societies, diagnosis research
prioritised by 42% of the societies, and prevention and control research prioritised by 39%
of the societies (see Appendix for plot).
Figure 2.
Proportion of 120 research priorities identified by UEG national society members, by major research
topic
20
15
10
5
Source: authors' compilation using sur vey data from UEG national society members .
White Book 2: Part 2
9
Drug therapy
Diagnosis
Prevention and control
Health care quality, access, and evaluation
Epidemiology
Pathology and physiopathology
Aetiology
Microbiology
Therapeutics (other) e.g. radiotherapy, rehabilitation
Complications
Genetics
Metabolism
Diet therapy
Economics e.g. cost analysis
Embryology
Immunology
Information science
Mortality
Surgical procedures, operative
Virology
% of research priorities

WhiteBook2_Part2

Table of Contents for the Digital Edition of WhiteBook2_Part2

WhiteBook2_Part2 - 1
WhiteBook2_Part2 - 2
WhiteBook2_Part2 - 3
WhiteBook2_Part2 - 4
WhiteBook2_Part2 - 5
WhiteBook2_Part2 - 6
WhiteBook2_Part2 - 7
WhiteBook2_Part2 - 8
WhiteBook2_Part2 - 9
WhiteBook2_Part2 - 10
WhiteBook2_Part2 - 11
WhiteBook2_Part2 - 12
WhiteBook2_Part2 - 13
WhiteBook2_Part2 - 14
WhiteBook2_Part2 - 15
WhiteBook2_Part2 - 16
WhiteBook2_Part2 - 17
WhiteBook2_Part2 - 18
WhiteBook2_Part2 - 19
WhiteBook2_Part2 - 20
WhiteBook2_Part2 - 21
WhiteBook2_Part2 - 22
WhiteBook2_Part2 - 23
WhiteBook2_Part2 - 24
WhiteBook2_Part2 - 25
WhiteBook2_Part2 - 26
WhiteBook2_Part2 - 27
WhiteBook2_Part2 - 28
WhiteBook2_Part2 - 29
WhiteBook2_Part2 - 30
WhiteBook2_Part2 - 31
WhiteBook2_Part2 - 32
WhiteBook2_Part2 - 33
WhiteBook2_Part2 - 34
WhiteBook2_Part2 - 35
WhiteBook2_Part2 - 36
WhiteBook2_Part2 - 37
WhiteBook2_Part2 - 38
WhiteBook2_Part2 - 39
WhiteBook2_Part2 - 40
WhiteBook2_Part2 - 41
WhiteBook2_Part2 - 42
WhiteBook2_Part2 - 43
WhiteBook2_Part2 - 44
WhiteBook2_Part2 - 45
WhiteBook2_Part2 - 46
WhiteBook2_Part2 - 47
WhiteBook2_Part2 - 48
WhiteBook2_Part2 - 49
WhiteBook2_Part2 - 50
WhiteBook2_Part2 - 51
WhiteBook2_Part2 - 52
WhiteBook2_Part2 - 53
WhiteBook2_Part2 - 54
WhiteBook2_Part2 - 55
WhiteBook2_Part2 - 56
https://www.nxtbookmedia.com